KDR Mutation as a Novel Predictive Biomarker of Exceptional Response to Regorafenib in Metastatic Colorectal Cancer

This is the case of an 84-year-old woman diagnosed with Stage IVb colon adenocarcinoma (CRC) metastatic to the liver, retroperitoneum, anastomotic site, and distal rectal sigmoid colon. She experienced intolerable side effects to systemic chemotherapy with 5-fluorouracil and bevacizumab, as well as...

Descripción completa

Detalles Bibliográficos
Autores principales: Loaiza-Bonilla, Arturo, Jensen, Christopher E, Shroff, Stuti, Furth, Emma, Bonilla-Reyes, Paula A, Deik, Andres F, Morrissette, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2016
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780686/
https://www.ncbi.nlm.nih.gov/pubmed/27004155
http://dx.doi.org/10.7759/cureus.478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780686/
https://www.ncbi.nlm.nih.gov/pubmed/27004155
http://dx.doi.org/10.7759/cureus.478

Ejemplares similares